UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities exchange act of 1934 Date of Report (Date of earliest event reported): January 20, 1997 MERIS LABORATORIES, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) California - -------------------------------------------------------------------------------- (State or other jurisdiction of incorporation or organization) 0-19360 77-0274078 - --------------------------- ------------------------------------------ (Commission file number) (I.R.S. Employer Identification No.) 2890 Zanker Road, San Jose, California 95134 - -------------------------------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 408-434-9200 Not Applicable - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) 1 Item 5. Other Events Effective January 20, 1997, the Company's common stock has been de-listed from the Nasdaq National Market due to its inability to meet certain Nasdaq minimum listing requirements. As a result, Nasdaq will notify the market makers that the Company's common stock has defaulted into the National Association of Securities Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded. (See Exhibit A for the press release issued for this event.) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MERIS LABORATORIES, INC. By: /s/ Thurman Jordan -------------------------------------- Thurman Jordan Senior Vice President - Finance (Duly authorized Officer and Principal Financial and Accounting Officer) Date: January 21, 1997 2 EXHIBIT A FOR IMMEDIATE RELEASE - --------------------- Contact: William McCormick President & CEO (408) 434-9200 x3710 Thurman Jordan Senior Vice President, Finance and CFO (408) 434-9200 x3722 MERIS LABORATORIES, INC. ANNOUNCES ITS COMMON STOCK DE-LISTED FROM NASDAQ NATIONAL MARKET San Jose, CA., January 20, 1997 - Meris Laboratories, Inc. (Nasdaq - MERS) announced that, effective today, its common stock has been de-listed from the Nasdaq National Market due to its inability to meet certain Nasdaq minimum listing requirements. As a result, Nasdaq will notify the market makers that the Company's common stock has defaulted into the National Association of Securities Dealers, Inc. (NASD) OTC Bulletin Board where it may be traded. # # # 3